Cargando…
Circ-CUL2/microRNA-888-5p/RB1CC1 axis participates in cisplatin resistance in NSCLC via repressing cell advancement
Elevated evidences manifest that circular RNAs (circRNAs) are vital in human tumor advancement and chemotherapy resistance. The study was to explore the character of Circ-CUL2 in non-small cell lung cancer (NSCLC). Firstly, the expression of circ-CUL2, microRNA (miR)-888-5p and RB1CC1 was detected i...
Autores principales: | Chen, HengQi, Li, Fang, Xue, Qi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8974128/ https://www.ncbi.nlm.nih.gov/pubmed/35068326 http://dx.doi.org/10.1080/21655979.2021.2024395 |
Ejemplares similares
-
Circ_0099630 Participates in SPRY1-Mediated Repression in Periodontitis
por: Wang, Jing, et al.
Publicado: (2022) -
RB1CC1 Activates RB1 Pathway and Inhibits Proliferation and Cologenic Survival in Human Cancer
por: Chano, Tokuhiro, et al.
Publicado: (2010) -
circRNA_103615 contributes to tumor progression and cisplatin resistance in NSCLC by regulating ABCB1
por: Liang, Hongguang, et al.
Publicado: (2021) -
RB1CC1 Together with RB1 and p53 Predicts Long-Term Survival in Japanese Breast Cancer Patients
por: Chano, Tokuhiro, et al.
Publicado: (2010) -
Preparation of Mouse Monoclonal Antibody for RB1CC1 and Its Clinical Application
por: Hama, Yusuke, et al.
Publicado: (2012)